Gurdev Dave Singh - Net Worth and Insider Trading
Gurdev Dave Singh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gurdev Dave Singh owns 1 companies in total, including Vivos Therapeutics Inc (VVOS) .
Click here to see the complete history of Gurdev Dave Singh’s form 4 insider trades.
Insider Ownership Summary of Gurdev Dave Singh
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
VVOS | Vivos Therapeutics Inc | 2020-12-10 | director & 10 percent owner & Chief Medical Officer |
Gurdev Dave Singh Trading Performance
Gurdev Dave Singh Ownership Network
Gurdev Dave Singh Owned Company Details
What does Vivos Therapeutics Inc do?
Who are the key executives at Vivos Therapeutics Inc?
Gurdev Dave Singh is the director & 10 percent owner & Chief Medical Officer of Vivos Therapeutics Inc. Other key executives at Vivos Therapeutics Inc include director & 10 percent owner & Chairman & CEO Ronald Kirk Huntsman , and Chief Financial Officer Bradford K. Amman .
Vivos Therapeutics Inc (VVOS) Insider Trades Summary
Over the past 18 months, Gurdev Dave Singh made no insider transaction in Vivos Therapeutics Inc (VVOS). Other recent insider transactions involving Vivos Therapeutics Inc (VVOS) include a net purchase of 39,021 shares made by Ronald Kirk Huntsman ,
In summary, during the past 3 months, insiders sold 0 shares of Vivos Therapeutics Inc (VVOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vivos Therapeutics Inc (VVOS) were sold and 1,561 shares were bought by its insiders, resulting in a net purchase of 1,561 shares.
Vivos Therapeutics Inc (VVOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vivos Therapeutics Inc Insider Transactions
Gurdev Dave Singh Mailing Address
Above is the net worth, insider trading, and ownership report for Gurdev Dave Singh. You might contact Gurdev Dave Singh via mailing address: 9137 Ridgeline Boulevard, Suite 135, Highlands Ranch Co 80129.